Guided Therapeutics EPS Est. T/T
Qual é o EPS Est. T/T de Guided Therapeutics?
O EPS Est. T/T de Guided Therapeutics, Inc. é N/A
Qual é a definição de EPS Est. T/T?
A taxa de crescimento prospectiva trimestral do EPS, ano após ano , é o aumento estimado do EPS de uma empresa para o próximo trimestre em comparação com o desempenho do trimestre passado correspondente.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
O que Guided Therapeutics faz?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.